Cargando…
Bacterial lysate add‐on therapy to reduce exacerbations in severe asthma: A double‐blind placebo‐controlled trial
BACKGROUND: Asthma exacerbations are frequently induced by respiratory tract infections (RTIs). Bacterial lysates have been described to possess immune‐modulatory effects and reduce RTIs as well as asthma symptoms in children. However, whether bacterial lysates have similar effects in adult asthma p...
Autores principales: | de Boer, Geertje M., Braunstahl, Gert‐Jan, van der Ploeg, Esmee K., van Zelst, Cathelijne M., van Bruggen, Alie, Epping, Guido, van Nimwegen, Menno, Verhoeven, Gert, Birnie, Erwin, Boxma‐de Klerk, Bianca M., de Bruijn, Marjolein J. W., Stadhouders, Ralph, Hendriks, Rudi W., Tramper‐Stranders, Gerdien A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292626/ https://www.ncbi.nlm.nih.gov/pubmed/34289183 http://dx.doi.org/10.1111/cea.13990 |
Ejemplares similares
-
Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort
por: de Boer, Geertje, et al.
Publicado: (2021) -
Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: a systematic review and meta-analysis
por: de Boer, Geertje Maria, et al.
Publicado: (2020) -
Antibiotic Prescriptions in Hospitalized Patients with an Exacerbation COPD and a Proven Influenza or RS Virus Infection
por: van Brummelen, Sigrid, et al.
Publicado: (2022) -
Type-2 CD8(+) T-cell formation relies on interleukin-33 and is linked to asthma exacerbations
por: van der Ploeg, Esmee K., et al.
Publicado: (2023) -
Asthma patients experience increased symptoms of anxiety, depression
and fear during the COVID-19 pandemic
por: de Boer, Geertje M, et al.
Publicado: (2021)